Huntington National Bank Intra Cellular Therapies, Inc. Transaction History
Huntington National Bank
- $14.8 Billion
- Q2 2025
A detailed history of Huntington National Bank transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1 shares of ITCI stock, worth $131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 244
99.59%
Holding current value
$131
Previous $32,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ITCI
# of Institutions
46Shares Held
12.2MCall Options Held
600Put Options Held
0-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.67MShares$220 Million0.13% of portfolio
-
Jpmorgan Chase & CO New York, NY760KShares$100 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL625KShares$82.4 Million0.27% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL519KShares$68.5 Million0.01% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...